These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 16449235)

  • 1. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.
    Wu JH; Gottlieb B; Batist G; Sulea T; Purisima EO; Beitel LK; Trifiro M
    Hum Mutat; 2003 Dec; 22(6):465-75. PubMed ID: 14635106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J; Mongan NP; Harland S; Hughes IA
    Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
    Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
    Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L859F mutation in androgen receptor gene results in complete loss of androgen binding to the receptor.
    Rajender S; Singh L; Thangaraj K
    J Androl; 2007; 28(5):772-6. PubMed ID: 17522416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens.
    Zhou J; Liu B; Geng G; Wu JH
    Proteins; 2010 Feb; 78(3):623-37. PubMed ID: 19787772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
    Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G708E mutation in the androgen receptor results in complete loss of androgen function.
    Rajender S; Pooja S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    J Androl; 2011; 32(2):193-8. PubMed ID: 20671138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding.
    Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    Fertil Steril; 2009 Mar; 91(3):933.e23-8. PubMed ID: 19062009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leu-676-Pro mutation of the androgen receptor causes complete androgen insensitivity syndrome in a large Hutterite kindred.
    Belsham DD; Pereira F; Greenberg CR; Liao S; Wrogemann K
    Hum Mutat; 1995; 5(1):28-33. PubMed ID: 7537149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
    Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
    MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
    Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutation analysis of the androgen receptor gene in a complete androgen insensitivity syndrome family].
    Wu W; Luo F; Geng Q; Hao Y; Chen W; Cai J; Xie J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):606-9. PubMed ID: 19953479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.